Multivalent Ligands to Control Stem Cell Fate
Multivalent Ligands to Control Stem Cell Fate
批准号:
9318607
负责人:
Ravi S. Kane
金额:
$32.81万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2019-06-30
关键词:
AdultAgonistAntibodiesBindingBiologicalBiologyBiomimeticsBiopolymersCell Culture SystemCell Differentiation processCell ProliferationCell surfaceCellsChemistryChimeric ProteinsComplexDevelopmentDevelopmental BiologyDimerizationEngineeringEphrin-B1Ephrin-B2EphrinsEventExtracellular MatrixHippocampus (Brain)HumanIn VitroIntegral Membrane ProteinInvestigationLearningLifeLigand BindingLigandsMediatingMedicineMemoryMethodsModelingNeurogliaNeurologicNeuronal DifferentiationNeuronsOrganOrganismParkinson DiseasePeptidesPhage DisplayPharmacologic SubstancePharmacology and ToxicologyPluripotent Stem CellsPost-Translational Protein ProcessingProcessPropertyPublic HealthReceptor CellRecombinantsRegenerative MedicineReplacement TherapyReproducibilityResearchSignal PathwaySignal TransductionStem cellsStructureSystemTherapeuticTimeWNT Signaling PathwayWnt proteinsWorkbasecell behaviordesigndimerdopaminergic neuronhuman diseasehuman embryonic stem cellhuman pluripotent stem cellin vivoinduced pluripotent stem cellmaterials sciencemood regulationnerve stem cellneurogenesisoverexpressionpolypeptidepublic health relevancereceptorsmall moleculestem cell differentiationstem cell fatetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The objective of the proposed work is to design potent multivalent ligands that influence the differentiation of adult neural stem cells (NSCs) and
human pluripotent stem cells (hPSCs) based on a biomimetic strategy - multivalency. Cellular signal transduction can often begin with the multivalent binding of ligands, either secreted or cell-surface tethered, to target cell receptors, leading to receptor clustering. The capacity to control multivalent interactions and thereby modulate key signaling events within living systems is, however, currently very limited. While antibody-induced ligand or receptor clustering has been achieved, this method is not well- controlled, efficient, or readily reproducible. Intracellulr targets can be clustered by the small-molecule dependent dimerization of repeated inducible dimerizing domains, but this approach involves overexpressing fusion proteins and is not readily applicable for endogenous ligands or receptors. The use of synthetic multivalent ligands is a promising approach to control and to elucidate fundamental mechanisms in cellular signaling. If such multivalent ligands could be designed to activate key signaling pathways and thereby control stem cell fate in vitro and in vivo, they could serve as both powerful biological tools and
as potent therapeutics. The first aim of the proposed work is to harness multivalent ephrin conjugates to study mechanisms by which Eph-ephrin signaling regulates cell fate decisions in neural stem cells and pluripotent stem cells. Within this aim, we will conduct a structure-function
analysis of ephrin multivalency in signaling and stem cell differentiation, as well as engineer peptide-based multivalent ligands for potent activation of Eph-ephrin signaling in vitro and in vivo. Our second aim is to determine whether multivalent conjugates can be engineered to activate Wnt signaling in NSCs, which will be achieved with a combination of engineering peptide-based multivalent ligands and characterizing their signaling properties in vitro and in vivo. We anticipate that the resulting multivalent ephrin and Wnt ligands will serve as potent bioactive materials for controlling stem cell fate decisions, a capability that would be significan for mechanistic investigations in stem cell and developmental biology in vitro and in vivo, as well
as for applications including enhanced cell culture systems, pharmacology and toxicology screens, and regenerative medicine approaches to restore organ function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds
-
批准号:10582942
-
项目类别:
-
资助金额:$85.2万
-
财政年份:2023
-
负责人:Ravi S. Kane
-
依托单位:
Design and Evolution of Polyvalent Domain Antibodies Specific for Tau Aggregates
-
批准号:10585480
-
项目类别:
-
资助金额:$42.19万
-
财政年份:2018
-
负责人:Ravi S. Kane
-
依托单位:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
-
批准号:9112133
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2015
-
负责人:Ravi S. Kane
-
依托单位:
Optogenetic Characterization and Control of Stem Cell Signaling
-
批准号:8674874
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2014
-
负责人:Ravi S. Kane
-
依托单位:
Multivalent Ligands to Control Stem Cell Fate
-
批准号:8762257
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2014
-
负责人:Ravi S. Kane
-
依托单位:
Optogenetic Characterization and Control of Stem Cell Signaling
-
批准号:9208064
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2014
-
负责人:Ravi S. Kane
-
依托单位:
Optogenetic Characterization and Control of Stem Cell Signaling
-
批准号:9000181
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2014
-
负责人:Ravi S. Kane
-
依托单位:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
-
批准号:8523855
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2012
-
负责人:Ravi S. Kane
-
依托单位:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
-
批准号:8345177
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2012
-
负责人:Ravi S. Kane
-
依托单位:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
-
批准号:8711082
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2012
-
负责人:Ravi S. Kane
-
依托单位:
Bioactive Materials for Stem Cell Control
-
批准号:7387048
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2008
-
负责人:Ravi S. Kane
-
依托单位:
Bioactive Materials for Stem Cell Control
-
批准号:7685288
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2008
-
负责人:Ravi S. Kane
-
依托单位:
The Design of Potent Divalent Inhibitors of HIV-1
-
批准号:6732052
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2003
-
负责人:Ravi S. Kane
-
依托单位:
The Design of Inhibitors of Anthrax Toxin
-
批准号:6678453
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2003
-
负责人:Ravi S. Kane
-
依托单位:
Design of Potent Divalent Inhibitors of HIV-1
-
批准号:6654232
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2003
-
负责人:Ravi S. Kane
-
依托单位:
The Design of Inhibitors of Anthrax Toxin
-
批准号:6773823
-
项目类别:
-
资助金额:$24.69万
-
财政年份:2003
-
负责人:Ravi S. Kane
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: